Amgen – Amgen Stock Over 3% Down So Far On Wednesday
Shares of Amgen dropped 3.24% to $232.70 at 11:39 EST on Wednesday, following last session’s upward trend. NASDAQ Composite is rising 0.13% to $13,630.77, after two consecutive sessions in a row of gains. This seems, as yet, a somewhat positive trend exchanging session today.
Amgen’s last close was $240.49, 18.90% under its 52-week high of $276.69.
Amgen’s sales growth is 3% for the current quarter and 5.4% for the next. The company’s growth estimates for the current quarter is a negative 1.2% and positive 1.9% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s last day, last week, and last month’s average volatility was 0.02%, 1.48%, and 1.14%, respectively.
Amgen’s last day, last week, and last month’s high and low average amplitude percentage was 2.17%, 4.90%, and 2.82%, respectively.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $232.70 at 11:39 EST, way below its 52-week high of $276.69 and way higher than its 52-week low of $177.05.
Amgen’s Moving Average
Amgen’s worth is under its 50-day moving average of $237.05 and under its 200-day moving average of $238.45.